The impact of parasite infections on the course of multiple sclerosis

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 6-11

  Correale, Jorge ^a   Farez, Mauricio F ^a  

^a FLENI   (Argentina)

Author keywords

Cytokines; Multiple sclerosis; Parasite infections; Regulatory T cells

Indexed keywords

ANTHELMINTIC AGENT; ANTIPARASITIC AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SECRETION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REGULATORY T LYMPHOCYTE; SYMPTOMATOLOGY;

ASCARIASIS; AUTOIMMUNE DISEASES; COHORT STUDIES; EOSINOPHILIA; FEMALE; HELMINTHIASIS; HOST-PARASITE INTERACTIONS; HUMANS; HYMENOLEPIASIS; MALE; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; PROSPECTIVE STUDIES; STRONGYLIDA INFECTIONS; TRICHURIASIS;

EID: 79953306426     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.01.002     Document Type: Article

References (20)

1. Abe M., Harpel J.G., Metz C.N., Loskuttoff D., Rifkin D.B. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994, 216:276-284.
2. Allen J.E., MacDonald A.S. Profound suppression of cellular proliferation mediated by the secretions of nematodes. Parasite Immunol. 1998, 20:241-247.
3. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920.
4. Correale J., Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 2007, 61:97-108.
5. Correale J., Farez M., Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann. Neurol. 2008, 64:187-199.
6. Doetze A., Satoguina J., Burchard G., Rau T., Loliger C., Fleischer B., Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int. Immunol. 2000, 12:623-630.
7. Elliott D.E., Metwali A., Leung J., Setiawan T., Blum A.M., Ince M.N., Bazzone L.E., Stadecker M.J., Urban J.F., Weinstock J.V. Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J. Immunol. 2008, 181:2414-2419.
8. Fleming J.O., Cook T.D. Multiple sclerosis and the hygiene hypothesis. Neurology 2006, 67:2085-2086.
9. Harnett W., Harnett M.M. Immunomodulatory activity and therapeutic potential of the filarial nematode secreted product, ES-62. Pathogen-derived Immunomodulatory Molecules 2009, Vol. 2009:88-94. Landes Bioscience/Springer Science, New York. P.G. Fallon (Ed.).
10. Harnett W., Harnett M.M., Byron O. Structural/functional aspects of ES-62 a secreted immunomodulatory phosphorylcholine-containing filarial nematode glycoprotein. Curr. Protein Pept. Sci. 2003, 4:59-71.
11. King C.L., Medhat A., Malhotra I., Nafeh M., Helmy A., Khaudary J., Ibrahim S., El-Sherbiny M., Zaky S., Stupi R.J., Brustoski K., Shehata M., Shata M.T. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J. Immunol. 1996, 156:4715-4721.
12. Lynch N.R., Hagel I., Perez M., Di Prisco M.C., Lopez R., Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allergy Clin. Immunol. 1993, 92:404-411.
13. Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M.D., Allen J.E. Helminth parasites - masters of regulation. Immunol. Rev. 2004, 201:89-116.
14. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
15. Raine T., Zaccone P., Dunne D.W., Cooke A. Can helminth antigens be exploited therapeutically to downregulate pathological Th1 responses?. Curr. Opin. Investig. Drugs 2004, 5:1184-1191.
16. Scrivener S., Yemaneberhan H., Zebenigus M., Tilahun D., Girma S., Ali S., McElroy P., Custovic A., Woodcock A., Pritchard D., Venn A., Britton J. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001, 358:1493-1499.
17. Summers R.W., Elliott D.E., Urban J.F., Thompson R.A., Weinstock J.V. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
18. van den Biggelaar A.H., Rodrigues L.C., van Ree R., van der Zee J.S., Hoeksma-Kruize Y.C., Souverijn J.H., Missinou M.A., Borrmann S., Kremsner P.G., Yazdanbakhsh M. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J. Infect. Dis. 2004, 189:892-900.
19. van der Kleij D., Latz E., Brouwers J.F., Kruize Y.C., Schmitz M., Kurt-Jones E.A., Espevik T., de Jong E.C., Kapsenberg M.L., Golenbock D.T., Tielens A.G., Yazdanbakhsh M. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 2002, 277:48122-48129.
20. Zaccone P., Fehérvári Z., Jones F.M., Sidabre S., Kronenberg M., Dunne D.W., Cooke A. Schistosoma mansoni antigens modualte the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 2003, 33:1439-1449.